Detection of the Mbcr/abl translocation in chronic myeloid leukemia by fluorescence in situ hybridization: Comparison with conventional cytogenetics and implications for minimal residual disease detection

Human Pathology

Volumn 28, Issue 2, 1997, Pages 154-159

  Garcia Isidoro, Maria ^b   Tabernero, Maria Dolores ^b   Garcia, Juan Luis ^b   Najera, Maria Luisa ^b   Hernandez, Jesus M ^b   Wiegant, Joop ^b   Raap, Anton ^b   San Miguel, Jesus ^b   Orfao, Alberto ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b NONE

Author keywords

bcr abl fusion; CML; FISH

Indexed keywords

BCR ABL PROTEIN;

ADULT; ARTICLE; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTERPHASE; MALE; METAPHASE CHROMOSOME; MINIMAL RESIDUAL DISEASE; PHILADELPHIA 1 CHROMOSOME; POLYMERASE CHAIN REACTION;

EID: 0031016147     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90099-X     Document Type: Article

References (45)

1. Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132:1497, 1960
2. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290-293, 1973
3. Fialkow PJ, Jacobson RJ, Papayannopoulou T: Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 63:125-130, 1977
4. Hagemeijer A: Chromosome abnormalities in CML. Ballieres Clin Haematol 1:963-981, 1987
5. Kurzrock R, Guttermman JU, Talpaz M: The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 319:990-998, 1988
6. De Klein A, van Kessel AG, Grosveld G, et al: A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature 300:765-767, 1982
7. Heisterkamp N, Stephenson JR, Groffen J, et al: Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukemia. Nature 306:239-242, 1983
8. Shitivelman E, Lifshitz B, Gale RP, et al: Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature 315:550-554, 1985
9. Allen PB, Morgan GJ, Wiedemann LM: Philadelphia chromosome-positive leukemia: The translocated genes and their gene products. Ballieres Clin Haematol 5:897-930, 1992
10. Canaani E, Gale RP, Steiner-Saltz D, et al: Altered transcription of an oncogen in chronic myeloid leukemia. Lancet i:593-595, 1984
11. Gale RP, Canaani E: Review: The molecular biology of chronic myelogenous leukemia. Br J Haematol 60:395-408, 1985
12. Talpaz M, Kantarjian HM, McCredie K, et al: Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. N Engl J Med 314:1065-1069, 1986
13. Kawasaki ES, Clark SS, Coyne MY, et al: Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Nad Acad Sci U S A 85:5698-5702, 1988
14. Strife A, Clarkson B: Biology of chronic myelogenous leukemia. Semin Hematol 25:1-19, 1988
15. Sawyers CL, Timson L, Kawasaki ES, et al: Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by the polymerase chain reaction. Proc Natl Acad Sci U S A 87:563-567, 1990
16. Talpaz M, Kantarjian HM, Kurzrock R, et al: Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Ann Intern Med 114:532-538, 1991
17. Lee MS, Kantarjian HM, Talpaz M, et al: Detection of minimal residual disease by polymerase chain reaction in Philadelphia-chromosome-positive chronic myelogenous leukemia following interferon therapy. Blood 79:1920-1923, 1992
18. Kantarjian HM, Deisseroth A, Kurzrock R, et al: Chronic myelogenous leukemia: A concise update. Blood 82:691-703, 1993
19. Gaiger A, Lion T, Kalhs P, et al: Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT). Leukemia 7:1766-1772, 1993
20. Zhao L, Hagop P, Kantarjian M, et al: Detection of residual proliferating leukemic cells by fluorescence in situ hybridization in CML patients in complete remission after interferon treatment. Leukemia 7:168-171, 1993
21. Cross NCP, Lin F, Chase A, et al: Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 82:1929-1936, 1993
22. Radich JP, Gehly G, Gooley T, et al: Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: Results and implications in 346 patients. Blood 85:2632-2638, 1995
23. Bartram CR, Carbonell F: Bcr rearrangement in Philadelphia-negative chronic myeloid leukemia. Cancer Genet Cytogenet 21:183-184, 1986
24. Ganesan TS, Rassool F, Guo AP, et al: Rearrangement of bcr gene in Philadelphia chromosome-negative chronic myeloid leukemia. Blood 68:957-960, 1986
25. Shtalrid M, Talpaz M, Blick M, et al: Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: Molecular analysis, clinical characteristics and response to therapy. J Clin Oncol 6:1569-1575, 1988
26. van der Plas D, Grosveld G, Hagemeijer A: Review of clinical cytogenetic and molecular aspects of Ph-negative CML. Cancer Genet Cytogenet 52:143-156, 1991
27. Dreazan O, Rassool F, Sparkes RS, et al: Do oncogenes determine clinical features in chronic myeloid leukemia? Lancet 1:1402-1405, 1987
28. Grossman A, Silver R, Szatrowski T, et al: Densitometric analysis of Southern blot autoradiographs and its application to monitoring patients with chronic myeloid leukemia. Leukemia 5:540-547, 1991
29. Lion T, Izraeli S, Henn T, et al: Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction. Leukemia 6:495-499, 1992
30. Verschraegen CF, Talpaz M, Hirsch-Ginsberg CF, et al: Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia. Blood 85:2705-2710, 1995
31. Bartram CR, de Klein A, Hagemeijer A, et al: Translocation of the c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukemia. Nature 306:277-280, 1983
32. Tkachuk DC, Westbrook CA, Andreeff M, et al: Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization. Science 250:559-562, 1990
33. Arnoldus EPJ, Wiegant J, Noordemeer IA, et al: Detection of the Philadelphia chromosome in interphase nuclei. Cytogenet Cell Genet 54:108-111, 1990
34. Bentz M, Cabot G, Moos M, et al: Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 83:1922-1928, 1994
35. Seong DC, Song MY, Henske EP, et al: Analysis of interphase cells for the Philadelphia translocation using painting probe made by inter-Alu-polymerase chain reaction from a radiation hybrid. Blood 83:2268-2273, 1994
36. Torlakovic E, Litz CE, McClure JS, et al: Direct detection of the Philadelphia chromosome in CD20-positive lymphocytes in chronic myeloid leukemia by tri-color immunophenotyping/FISH. Leukemia 8:1940-1943, 1994
37. Amiel A, Yarkoni S, Slavin S, et al: Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization. Cancer Genet Cytogenet 76:59-64, 1994
38. Tabernero MD, San Miguel JF, Garcia JL, et al: Clinical, biological and immunological characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization. Cytometry 22:217-222, 1995
39. Wiegant J, Ried T, Nederlof PM, et al: In situ hybridization with fluoresceinated DNA. Nucleic Acids Res 19:3237-3241, 1991
40. Arnoldus EPJ, Noordemeer IA, Peters ACB, et al: Interphase Cytogenetics of brain tumors. Gene Chromosome Cancer 3:101-107, 1991
41. Dixon WJ (ed): BMDP Statistical Software. Berkeley, CA, University of California, 1983
42. Garicochea B, Chase A, Lazaridou A, et al: T-lymphocytes in chronic myelogenous leukemia (CML): No evidence of the BCR/ ABL fusion gene detected by fluorescence in situ hybridization in 14 patients. Leukemia 8:1197-1201, 1994
43. Dewald GW, Schad CR, Christensen ER, et al: The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL. Cancer Genet Cytogenet 71:7-14, 1993
44. Seong DC, Kantarjian HM, Ro JY, et al: Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment. Blood 86:2343-2349, 1995
45. Szczylik C, Skorski T, Nicolaides NC, et al: Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligonucleotides. Science 253:562-565, 1991